dc.contributor.author | Labrou, NE | en |
dc.contributor.author | Eliopoulos, E | en |
dc.contributor.author | Clonis, YD | en |
dc.date.accessioned | 2014-06-06T06:43:11Z | |
dc.date.available | 2014-06-06T06:43:11Z | |
dc.date.issued | 1996 | en |
dc.identifier.issn | 02646021 | en |
dc.identifier.uri | http://62.217.125.90/xmlui/handle/123456789/1078 | |
dc.relation.uri | http://www.scopus.com/inward/record.url?eid=2-s2.0-0030000366&partnerID=40&md5=2abc0108def79b2ef9e1ae705c12eb47 | en |
dc.subject.other | amide | en |
dc.subject.other | anthraquinone | en |
dc.subject.other | carboxyl group | en |
dc.subject.other | cibacron blue f3ga | en |
dc.subject.other | dye | en |
dc.subject.other | malate dehydrogenase | en |
dc.subject.other | oxaloacetic acid | en |
dc.subject.other | oxoacid | en |
dc.subject.other | reduced nicotinamide adenine dinucleotide | en |
dc.subject.other | animal cell | en |
dc.subject.other | article | en |
dc.subject.other | binding affinity | en |
dc.subject.other | cattle | en |
dc.subject.other | chromatophore | en |
dc.subject.other | competitive inhibition | en |
dc.subject.other | controlled study | en |
dc.subject.other | enzyme active site | en |
dc.subject.other | enzyme binding | en |
dc.subject.other | enzyme inactivation | en |
dc.subject.other | enzyme inhibition | en |
dc.subject.other | heart mitochondrion | en |
dc.subject.other | hydrophobicity | en |
dc.subject.other | molecular model | en |
dc.subject.other | nonhuman | en |
dc.subject.other | priority journal | en |
dc.subject.other | spectrometry | en |
dc.subject.other | titrimetry | en |
dc.subject.other | Affinity Labels | en |
dc.subject.other | Animals | en |
dc.subject.other | Anthraquinones | en |
dc.subject.other | Binding Sites | en |
dc.subject.other | Cattle | en |
dc.subject.other | Coloring Agents | en |
dc.subject.other | Drug Design | en |
dc.subject.other | Enzyme Inhibitors | en |
dc.subject.other | Ligands | en |
dc.subject.other | Malate Dehydrogenase | en |
dc.subject.other | Mitochondria, Heart | en |
dc.subject.other | Models, Molecular | en |
dc.subject.other | Triazines | en |
dc.subject.other | Animalia | en |
dc.subject.other | Bos taurus | en |
dc.subject.other | Bovinae | en |
dc.title | Molecular modelling for the design of chimaeric biomimetic dye-ligands and their interaction with bovine heart mitochondrial malate dehydrogenase | en |
heal.type | journalArticle | en |
heal.publicationDate | 1996 | en |
heal.abstract | Molecular modelling and kinetic inhibition studies, as well as K(D) determinations by both difference-spectra and enzyme-inactivation studies, were employed to assess the ability of purpose designed chimaeric biomimetic dyes (BM dyes) to act as affinity ligands for bovine heart L-malate dehydrogenase (MDH). Each BM dye was composed of two enzyme-recognition moieties. The terminal biomimetic moiety bore a carboxyl or a keto acid structure linked to the triazine ring, thus mimicking the substrate of MDH. The chromophore anthraquinone moiety remained unchanged and the same as that of the parent dye Vilmafix Blue A-R (VBAR), recognizing the nucleotide-binding site of MDH. The monochlorotriazine BM dyes did not inactivate MDH but competitively inhibited inactivation by the parent dichlorotriazine dye VBAR. Dye binding to MDH was accompanied by a characteristic spectral change in the range 500-850 nm. This phenomenon was reversed after titration with increasing amounts of NADH. When compared with VBAR, Cibacron Blue 3GA and two control non-biomimetic anthraquinone dyes, all BM dyes exhibited lower K(D) values and therefore higher affinity for MDH. The enzyme bound preferably to BM ligands substituted with a biomimetic aromatic moiety bearing an α-keto acid group and an amide linkage, rather than a monocarboxyl group. Thus the biomimetic dye bearing p-aminobenzyloxanilic acid as its terminal biomimetic moiety (BM5) exhibited the highest affinity (K(D) 1.3 μM, which corresponded to a 219-fold decrease over the K(D) of a control dye). BM5 displayed competitive inhibition with respect to both NADH (K(i) 2.7 μM) and oxaloacetate (K(i) 9.6 μM). A combination of molecular modelling and experimental studies has led to certain conclusions. The positioning of the dye in the enzyme is primarily achieved by the recognition and positioning of the nucleotide-pseudomimetic anthraquinone moiety. The hydrophobic groups of the dye provide the driving force for positioning of the ketocarboxyl biomimetic moiety. A match between the alternating polar and hydrophobic regions of the enzyme binding site with those of the biomimetic moiety is desirable. The length of the biomimetic moiety should be conserved in order for the keto acid to approach the enzyme active site and form charge-charge interactions. | en |
heal.journalName | Biochemical Journal | en |
dc.identifier.issue | 2 | en |
dc.identifier.volume | 315 | en |
dc.identifier.spage | 695 | en |
dc.identifier.epage | 703 | en |
Αρχεία | Μέγεθος | Μορφότυπο | Προβολή |
---|---|---|---|
Δεν υπάρχουν αρχεία που σχετίζονται με αυτό το τεκμήριο. |